Multiplex panel dual immunohistochemistry using p63/CK 5 and TTF-1/Napsin A are useful in subcategorising NSCLC-NOS into SCC and ADC phenotypes[7]. This evidence concerns the gene TTF1 and non-small cell lung carcinoma.